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Across Europe, the role of the welfare state is constantly being questioned and even eroded. At the same time, funding sources for post-gradu-
ate medical education and training are under attack as regulators review the working relationships between physicians and industry. Both of
these issues have profound consequences for cardiologists and their patients, and were, therefore, chosen as the themes of the European Heart
Rhythm Association (EHRA) 2014 Spring Summit held at Heart House, Sophia Antipolis, 25–26 March 2014. The meeting noted that some of
the changes are already affecting patient care standards and that this is exacerbated by a reduction in research and education programmes. The
principle conclusion was that EHRA must find better means of engagement with the authorities across Europe to ensure that its views are
considered and that ethical patient care is preserved. Participants were particularly alarmed by the example from Sweden in which future
healthcare planning appears to exclude the views of physicians, although this is not yet the case in other countries. The demand for greater
transparency in relationships between physicians and industry was also discussed. Although intended to eliminate corruption, concern was
expressed that such moves would cause long-term damage to education and research, threatening the future of congresses, whose role in these
areas appears underestimated by the authorities.
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Introduction
The European Heart Rhythm Association (EHRA) Summit is an an-
nual meeting that brings together senior representatives of EHRA
and National Cardiac Societies to debate high-level strategic issues.
The agenda of the 2014 Summit, held at Heart House, addressed
two principle topics:
† the end of the welfare state, and
† the future of research and medical education.
The organizing committee brought together prominent speakers re-
presenting physicians, pharmaceutical and device manufacturers, hos-
pital managers, politicians, health economists, and medical insurance
providers. The major discussion points are summarized in this paper.
Is the welfare state at risk?
There is no common funding model for the so-called welfare state in
Europe. Individual countries offer a range of public healthcare ser-
vices for qualifying citizens, funded by a variety of means spanning
voluntary insurance-based schemes to mandatory taxation-based
contributions. More than ever before, healthcare expenditure is un-
der intense pressure and is even declining in some countries. Public
ownership of hospitals and healthcare services means that ongoing
cost-cutting is inevitable. Budgets in the form of state funding are,
at best, frozen while many aspects of cost continue to rise.
The UK is a good example of a welfare state in retreat but work-
ing hard to reduce cost. The healthcare budget shows year-on-year
growth of 2.6% but, allowing for inflation, this is actually a cost re-
duction.1 The UK’s National Institute of Clinical Excellence
(NICE) was established to combat increasing expenditure and Q3en-
sure value for money (http://www.nice.org.uk/guidance/conditions-
and-diseases/cardiovascular-conditions/heart-rhythm-conditions).
Progressive centralization has lowered costs by establishing
centres-of-excellence, for instance, stroke treatment in London is
now centred at four hospitals rather than 30. Sixty per cent of the
total healthcare budget is delegated to family doctors who can ne-
gotiate with hospitals for the best deal, while some level of compe-
tition with private hospitals is allowed. Physicians are represented
on the various NICE approval committees to consider the available
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evidence that informs decisions. Overall, NICE is considered an ef-
fective body that has delivered on its objectives.
This contrasts with the situation in Sweden where reductions in
cardiovascular-related mortality have been achieved at high cost. To
help the shift from ‘volume’ to ‘value’, Sweden is introducing a new
system of healthcare employing multi-disciplinary teams with long-
term follow-up. The indications at this stage suggest that physicians
will have only a very small role in this initiative and therefore be ex-
cluded from much of the care decision-making. Understandably, this
is a matter of great concern.
The welfare state funding crisis
Welfare costs, including healthcare, can absorb up to 25% of nation-
al GDP and are forecast to increase at 10% per annum.1 This is un-
sustainable in an era of falling tax revenues, stagnant growth, and
high unemployment. In addition, major demographic trends includ-
ing increased life expectancy and high levels of migration exacerbate
the scale of the problem. Few, however, are brave enough to predict
the demise of the welfare state and public healthcare will almost cer-
tainly remain a core institution in the majority of European coun-
tries. Changes are essential so that funding models can adapt and
be prioritized, even so the quality and level of services provided
will probably need to reduce.
What role for insurers?
Insurance providers may have a role to play in bridging the gap.
Around 33% of German citizens are covered by statutory insurance
at a regional level on a pay-as-you-go basis. Providers do more than
reimburse hospitals; however, they are deeply involved in planning,
risk assessment, and data collection as well. The outcome is that
well-staffed, high quality services are available at short notice. Yet,
even in Germany, economic sustainability is an obvious and pressing
issue which will inevitably lead to a reduction in service standards
despite valid attempts to manage costs through efficiency gains, bet-
ter diagnosis, avoiding waste, and integration of inpatient and out-
patient care.
The view from manufacturers
Manufacturers are concerned about the future. They report that
many European countries are still failing to meet agreed implemen-
tation targets for certain procedures.2,3 This causes problems be-
cause the shortfall in device use ultimately hits manufacturers’
revenue and profit, making it even harder to justify long-term invest-
ment. Industry has to be profitable to continue to innovate the next
generation of technologies. Without investment, the promise of
new initiatives such as telemedicine and remote monitoring will
not happen. There is no doubt that reimbursement has played a
part in the general uncertainty. Even when efficacy of a new drug
or device is proved, the necessary approvals can still be subject to
lengthy delays.
Manufacturers observe that important purchasing decisions for
drugs and devices are driven purely by commercial factors, often
without the input of physicians. European Heart Rhythm Associ-
ation itself and its individual members are urged to be proactive
and ensure representation when such decisions are taken. European
Heart Rhythm Association must be better prepared to ‘play the sys-
tem’ and investigate ways to influence policy in Brussels. It must con-
vince EU and national governments that healthcare is a wise
investment, and recognize that regulatory pressures and calls for
greater transparency are a fact of life.
Transparency—necessity or
witch-hunt?
The medical devices industry has always operated within a strict le-
gislative framework. This is hardly surprising given the importance of
its products to cardiovascular medicine. Now, however, the burden
is increasing with growing demands to regulate relationships be-
tween physicians and industry to ensure transparency and, ultimate-
ly, eliminate corruption. The new rules cover disclosure by
physicians of their support from, and involvement with, industry.
EUCOMED is very concerned that these new regulations will inad-
vertently cause great damage to post-graduate education by under-
mining the funding model for congresses and meetings. The
consensus was that this move will adversely impact R&D and innov-
ation as well as congresses and leave the question who will pay for
post-graduate medical education in the future? Sweden has already
acted independently and has banned funding for congress attend-
ance and may even restrict educational grants. From the beginning
of 2014, Swedish physicians have had to file detailed reports of
industrial support and return any unspent funds.
Challenges in education and
research
Education is undergoing a period of great change, but also one of
great opportunity. Traditional learning platforms such as congresses
and industry partnerships are under intense regulatory scrutiny to
comply with transparency demands. If cardiologist cannot rely on
congresses, where do they turn for education? Evidence-based edu-
cation is one answer, exploiting outreach sessions, webinars, fellow-
ship grants, and certification. Knowledge-based CME must shift
towards professional development and performance improvement.
European Society of Cardiology and EHRA can be at the forefront of
this by bringing together all stakeholders—indeed ESC is already
planning to position itself as the Post-Graduate Academy of
Cardiology.
The methods available to capture clinical research evidence in-
clude Randomized Clinical Trials (RCTs), Surveys, Registries, and
Observational Studies. Randomized Clinical Trials are very complex
and expensive, and can be slow to deliver results.4 The conclusion,
however, is that neither Surveys nor Registries can replace RCTs for
novel therapies although costs certainly need to be reduced. Sur-
veys can, however, be used to address the high cost of mortality
and morbidity trials. Basic research is another matter of concern,
with government funding often falling behind the rise in general
healthcare budgets. One notable exception is China, where high
spending is a feature of its strategy. Richer countries can afford to
spend more but rarely do.
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Relationships between physicians
and administrators
In France, at least, physicians continue to play a leading role in stra-
tegic healthcare decisions. They act as expert advisors and also carry
some executive responsibilities. French policy positions hospitals as
a public service. Relations between physicians and administrators
have room for improvement although new measures have been ta-
ken to build confidence and establish a firm platform for develop-
ment. The welfare state in France will be preserved, and there is a
determination to ensure that physicians remain closely involved in
quality of care and management decisions.5
What about private hospitals? Using Spain as a case study, it was
reported that public health is in deep crisis having endured a 33%
budget cut in 2013. This has forced collaboration between public
and private sectors and also established a foundation for better re-
lationship between physicians and administrators. Around 25% of
the total healthcare budget is spent on private medicine, and seven
million individuals pay into insurance schemes. The scale of the pri-
vate sector in Spain, in contrast to other European countries, is such
that it can take some of the load that public services cannot meet. In
this environment, physicians and administrators both appreciate
that they have roles to play. Their joint goals are commercial
(such as financial and operational targets) and care-related (such
as quality of care and re-admission rates).
Reforming the welfare state—a
UK view
Against the backdrop of an economic crisis, it is tempting to ques-
tion the viability of the UK’s Welfare State. From its launch in 1948,
the National Health Service was supposed to lower overall cost by
improving the health of citizens. Yet the opposite has happened,
albeit with a 10-year increase in life expectancy. New legislation in
2012 considered aspects such as preventable early death, treating
dementia and mental illness, managing chronic conditions, and ap-
plying technology solutions to the challenges of health and long-
term care. Paying for these noble aims, however, is conditional on
achieving 4% efficiency savings across the whole NHS.
The UK’s NICE agency is playing an important role in delivering
these savings by providing stakeholders evidence-based guidance,
developing quality standards and performance metrics, and pro-
viding a wealth of information to inform decision-making.3 The
new era also allows for competition between hospitals and other
care providers, and is introducing personalized healthcare budgets
to drive greater patient involvement. Difficult issues still need to
be addressed including centralization, facilities closures, and ra-
tioning of certain treatments. The conclusion from the UK is
that the Welfare State is not at the end of its life, but serious
and continuing reform is essential to control expenditure and
shape future services.
Funding of scientific societies
Increasingly, cardiologists across Europe are finding it more difficult
to keep up-to-date with new advances in treatment. The German
Cardiac Society reports fewer abstracts being submitted ahead of
meetings and conferences. Part of the reason may be that cardiolo-
gists cannot find the time to attend despite the known advantages of
education and networking opportunities. The increase in private
hospitals is another factor, with the implication that employers out-
side the public sector are less willing to support academic activity.
In Switzerland, the situation is complex with a number of different
hospital systems providing services. Insurance is mandatory for all
citizens. Until 2012, physicians could attend meetings of their choice
with the costs covered by the respective canton. Since then, how-
ever, a DRG reimbursement system has been introduced with no
provision for education and research. This has changed the landscape
considerably, with non-vacation absences limited to a maximum of
20 days each year. The fact that participation at congresses is redu-
cing suggests great pressure is being applied to maximizing hospital
efficiency and income at the expense of education.
Slovakia is an interesting case. All scientific activities by physicians
have to be reported and education is not tax-deductible. There is a
feeling that academic medicine is being deliberately undermined and
that education and research are seen as obstacles to more efficient
healthcare. The government has erected barriers between physi-
cians and industry in its attempts to lower the cost of healthcare,
aided in some ways by the media. The overall aim seems to be to
slow the therapeutic process with cost-containment being the im-
mediate benefit.
The ESC itself remains optimistic, believing that cooperation be-
tween professional physicians is vital to progress. The virtual world
will inevitably play a bigger role in future education projects and
help to maintain the common bond that draws professionals to-
gether. The uncertainty over future congress funding is an issue to
address; however, it was noted that while education has been largely
free in ESC countries, this is not the case outside Europe. Flexibility
is the key.
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